Cystic fibrosis related diabetes - A new perspective on the optimal management of postprandial glycemia

Journal of Diabetes and its Complications

Volumn 28, Issue 6, 2014, Pages 904-911

  Perano, S ^a,b   Rayner, C K ^b,c   Couper, J ^a,b   Martin, J ^a   Horowitz, M ^b,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cystic fibrosis related diabetes; Gastric emptying; Incretins; Pancreatic enzymes; Postprandial glycemia

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; C PEPTIDE; CHOLECYSTOKININ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXENDIN 4; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; PANCREAS ENZYME; PEPTIDE YY; PROTON PUMP INHIBITOR; SULFONYLUREA; TRIACYLGLYCEROL LIPASE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GLUCOSE BLOOD LEVEL; HORMONE RECEPTOR;

AGONIST; CARBOHYDRATE INTOLERANCE; CARBOHYDRATE METABOLISM; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; DUMPING SYNDROME; FAT CONTENT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; LUNG TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS EXOCRINE INSUFFICIENCY; PATHOGENESIS; PREVALENCE; REVIEW; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; PHYSIOLOGY; POSTPRANDIAL STATE; STOMACH EMPTYING;

BLOOD GLUCOSE; CYSTIC FIBROSIS; DIABETES MELLITUS, TYPE 2; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPERGLYCEMIA; INCRETINS; INSULIN; POSTPRANDIAL PERIOD; PREVALENCE; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 84908352104     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.06.012     Document Type: Review

References (61)

1. H. Anthony, C.E. Collins, G. Davidson, C. Mews, P. Robinson, and R. Shephard Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines Journal of Paediatrics and Child Health 35 1999 125 129
2. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
3. J.L. Barnett, and C. Owyang Serum glucose concentration as a modulator of interdigestive gastric motility Gastroenterology 94 1988 739 744
4. A. Battezzati, A. Mari, L. Zazzeron, G. Alicandro, L. Claut, and P.M. Battezzati Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients European Journal of Endocrinology 165 2011 69 76
5. G. Belle-van Meerkerk, E.A. van de Graaf, J.M. Kwakkel-van Erp, D.A. van Kessel, J.W. Lammers, and D.H. Biesma Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases Diabetic Medicine 29 2012 e159 e162
6. M.D. Bellin, T. Laguna, J. Leschyshyn, W. Regelmann, J. Dunitz, and J. Billings Insulin secretion improves in cystic fibrosis following ivancaftor correction of CFTR: A small pilot study Pediatric Diabetes 14 2013 417 421
7. Bethesda Annual Data Report for the Cystic Fibrosis Foundation Patient Registry for the year of 2010. USA Available from: http://www.cff.org/UploadedFiles/research/ClinicalResearch/2010-Patient-Registry.pdf (Last accessed 1st June 2013)
8. C. Bizzarri, V. Lucidi, P. Ciampalini, S. Bella, and M. Cappa Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance Journal of Endocrinological Investigation 29 2006 1 4
9. A.L. Brennan, K.M. Gyi, and D.M. Wood Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis Journal of Cystic Fibrosis 6 2007 101 109
10. C.E. Collins, J.L. Francis, P. Thomas, R.L. Henry, and E.V. O'Loughlin Gastric emptying time is faster in cystic fibrosis Journal of Pediatric Gastroenterology and Nutrition 25 1997 492 498
11. M. Couce, T.D. O'Brien, A. Moran, P.C. Roche, and P.C. Butler Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis The Journal of Clinical Endocrinology and Metabolism 81 1996 1267 1272
12. K.M. Cunningham, J. Daly, M. Horowitz, and N. Read Gastrointestinal adaptation to diets of differing fat composition in human volunteers Gut 32 1991 483 486
13. Cystic Fibrosis in Australia 2011 15th Annual Report from the Australian Cystic Fibrosis Data Registry 2012
14. A. Egan, E. Blind, K. Dunder, P. Graeff, B.T. Hummer, and T. Bourcier Pancreatic safety of incretin-baed drugs - FDA and EMA assessment The New England Journal of Medicine 370 2014 794 797
15. W.K. Fakhoury, C. Lereun, and D. Wright A meta-analysis of placebo-controlled clinical trials assessing the efficacy and safety of incretin-based medications in patients with type 2 diabetes Pharmacology 86 2010 44 57
16. D. Gentilcore, R. Chaikomin, K.L. Jones, A. Russo, C. Feinle-Bisset, and J. Wishart Effects of fat on gastric emptying of and the glycemic, insulin and incretin responses to a carbohydrate meal in type 2 diabetes The Journal of Clinical Endocrinology and Metabolism 91 2006 2062 2067
17. L. Guarner, R. Rodriguez, F. Guarner, and J.R. Malagelada Fate of oral enzymes in pancreatic insuffiency Gut 34 1993 708 712
18. S. Hameed, J. Morton, A. Jaffe, P. Field, Y. Belessis, and T. Young Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain Diabetes Care 33 2010 221 226
19. R. Hanna, and D. Weiner Overweight and obesity in cystic fibrosis patients North American Cystic Fibrosis Conference; Orlando, FL 2012 419
20. J.J. Holst, and T. Vilsboll Combining GLP 1 receptor agonists with insulin: Therapeutic rationales and clinical findings Diabetes, Obesity & Metabolism 15 2013 3 14
21. M. Horowitz, J.M. Edelbroek, J. Wishart, and J.W. Straathof Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects Diabetologia 36 1993 857 862
22. C.J. Huang, L. Haataja, T. Gurlo, A.E. Butler, X. Wu, and W.C. Soeller Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide American Journal of Physiology - Endocrinology & Metabolism 293 2007 1656 1662
23. C.J. Huang, C.Y. Lin, L. Haataja, T. Gurlo, A.E. Bulter, and R.A. Rizza High expression rates of human islet amyloid polypeptide induced endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes Diabetes 56 2007 2016 2027
24. S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, and M. Nauck Management of hyperglycaemia in type 2 diabetes: A patient-centred approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 35 2013 1364 1379
25. C. Kapitza, H. Coester, F. Poitiers, G. Heumann, P. Ruus, and A. Hincelin-Mery Pharmacodynamic characteristics of lixisenatide QD vs liraglutide QD in patients with T2DM inadequately controlled with metformin [Abstract] World Diabetes Congress 2011 (D-0740)
26. P. Kuo, J. Stevens, A. Russo, A. Maddox, J. Wishart, and K. Jones Gastric emptying, incretin hormone secretion and postprandial glycaemia in cystic fibrosis-effects of pancreatic enzyme supplementation The Journal of Clinical Endocrinology and Metabolism 96 2011 851 855
27. S. Lanng, A. Hansen, B. Thorsteinsson, J. Nerup, and C. Koch Glucose tolerance in patients with cystic fibrosis: Five year prospective study British Medical Journal 311 1995 655 659
28. S. Lanng, B. Thorsteinsson, F. Pociot, M.O. Marshall, H.O. Madsen, and M. Schwartz Diabetes mellitus in cystic fibrosis: Genetic and immunological markers Acta Paediatrica 82 1993 150 154
29. S. Lanng, B. Thorsteinsson, M.E. Roder, C. Orskov, J.J. Holst, and J. Nerup Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance Acta Endocrinologica 128 1993 207 214
30. J. Littlewood, D. Bilton, N. Bridges, K. Gyi, M. Hodson, and M. Jones UK Cystic Fibrosis Trust Diabetes Working Group Management of cystic fibrosis related diabetes mellitus UK Cystic Fibrosis Trust 2004 (Available at: https://www.cysticfibrosis.org.uk/ Last accessed 15 August 2013)
31. W.B. Long, and J.B. Weiss Rapid gastric emptying of fatty meals in pancreatic insufficiency Gastroenterology 67 1974 920 925
32. J. Ma, A.N. Pilichiewicz, C. Feinle-Bisset, J.M. Wishart, K.L. Jones, and M. Horowitz Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes Diabetic Medicine 29 2012 604 608
33. J. Ma, J.E. Stevens, K. Cukier, A.F. Maddox, J.M. Wishart, and K.L. Jones Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes Diabetes Care 32 2009 1600 1602
34. C. Marathe, C. Rayner, K. Jones, and M. Horowitz Relationship between gastric emptying, postprandial glycaemia, and incretin hormones Diabetes Care 36 2013 1396 1405
35. B.C. Marshall, S.M. Butler, M. Stoddard, A.M. Moran, T.G. Liou, and W.J. Morgan Epidemiology of cystic fibrosis-related diabetes The Journal of Pediatrics 146 2005 681 687
36. J.J. Meier, B. Baller, B.A. Menge, B. Gallwitz, W.E. Schmidt, and M.A. Nauck Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: Is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa? Diabetes, Obesity & Metabolism 11 2009 213 222
37. J.H. Meyer, and R. Lake Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres Pancreas 15 1997 226 235
38. A. Moran, C. Brunzell, R.C. Cohen, M. Katz, B. Marshall, and G. Onady Clinical care guidelines for cystic fibrosis-related diabetes: A position statement for the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society Diabetes Care 33 2010 2697 2708
39. A. Moran, P. Diem, D.J. Klein, M.D. Levitt, and R.P. Robertson Pancreatic endocrine function in cystic fibrosis The Journal of Pediatrics 118 1991 715 723
40. A. Moran, J. Dunitz, B. Nathan, A. Saeed, B. Holme, and W. Thomas Cystic fibrosis-related diabetes: Current trends in prevalence, incidence, and mortality Diabetes Care 32 2009 1626 1631
41. A. Moran, D. Hardin, D. Rodman, H. Allen, R. Beall, and D. Borowitz Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report Diabetes Research and Clinical Practice 45 1999 61 73
42. A. Moran, P. Pekow, P. Grover, M. Zorn, B. Slovis, and J. Pilewski Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia Diabetes Care 32 2009 1783 1788
43. M.A. Nauck, U. Niedereichholz, R. Ettler, J.J. Holst, C. Orskov, and R. Ritzel Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans The American Journal of Physiology 273 1997 981 988
44. D. O'Donovan, M. Horowitz, A. Russo, C. Feinle-Bisset, N. Murolo, and D. Gentilcore Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes Diabetologia 47 2004 2208 2214
45. G.M. Onady, and A. Stolfi Insulin and oral agents for managing cystic fibrosis related diabetes (Review) Cochrane Database of Systematic Reviews 2 2013 10.1002/14651858.pub3 (Art. No: CD004730)
46. S. O'Riordan, P. Robinson, K.C. Donaghue, and A. Moran Management of cystic fibrosis-related diabetes in children and adolescents Pediatric Diabetes 10 Suppl. 12 2009 43 50
47. A. Pauwels, K. Blondeau, V. Merens, R. Farre, K. Verbeke, and L. Dupont Gastric emptying and different types of reflux in adult patients with cystic fibrosis Alimentary Pharmacology & Therapeutics 34 2011 799 807
48. S. Perano, J. Couper, M. Horowitz, J. Martin, S. Kritas, and T. Sullivan Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycaemia in adolescents with cystic fibrosis: A randomized crossover trial The Journal of Clinical Endocrinology and Metabolism 2014 10.1210/jc.2013-4417 (Advanced online publication)
49. M. Rana, C.F. Munns, H. Selvadurai, K.C. Donaghue, and M.E. Craig Cystic fibrosis-related diabetes in children - Gaps in the evidence? Nature Reviews. Endocrinology 6 2010 371 378
50. M. Rana, C. Munns, H. Selvadurai, S. Simonds, P. Cooper, and H. Woodhead Increased detection of cystic fibrosis related diabetes in Australia Archives of Disease in Childhood 96 2011 823 826
51. M. Roulet, A.M. Weber, Y. Paradis, C.C. Roy, L. Chartrand, and R. Lasalle Gastric emptying and lingual lipase activity in cystic fibrosis Pediatric Research 14 1980 1360 1362
52. E. Schvarcz, M. Palmer, J. Aman, and C. Berne Hypoglycemia increases the gastric emptying rate in healthy subjects Diabetes Care 18 1995 674 676
53. S.J. Schwarzenberg, W. Thomas, T.W. Olsen, T. Grover, D. Walk, and C. Milla Microvascular complications in cystic fibrosis-related diabetes Diabetes Care 30 2007 1056 1061
54. N. Sulli, and B. Shashaj Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus decreases HbA1c with low risk of hypoglycaemia Journal of Pediatric Endocrinology & Metabolism 16 2003 393 399
55. E. Symonds, T. Omari, J. Wester, G. Davidson, and R. Butler Relationship between pancreatic lipase activity and gastric empyting rate in children with cystic fibrosis The Journal of Pediatrics 143 2003 772 775
56. C.J. Taylor, P.G. Hillel, S. Ghosal, M. Frier, S. Senior, and W.B. Tindale Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis Archives of Disease in Childhood 80 1999 149 152
57. S. Tofe, J. Moreno, L. Maiz, M. Alsonso, H. Escobar, and R. Barrio Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis European Journal of Endocrinology 152 2005 241 247
58. L.G. Trahair, M. Horowitz, C.K. Rayner, D. Gentilcore, K. Lange, and J.M. Wishart Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects The Journal of Clinical Endocrinology and Metabolism 97 2012 844 851
59. M. Umapathysivan, M. Lee, K. Jones, C. Annink, C. Cousins, and L.G. Trahair Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia Diabetes 63 2014 785 790
60. F. Valour, C. Brault, F. Aabbas-Chorfa, C. Martin, L. Kessler, and H. Mosnier-Puder Outcome of cystic fibrosis-related diabetes two years after lung transplantation Respiration 86 2013 32 38
61. L. Viviani, A. Zolin, and H.V. Olesen European Cystic Fibrosis Society Annual Data Report 2008-2009 (Version 03.2012)